Latest DEF 14A proxy statements

Leading proxy advisory firm ISS recommends Neuphoria shareholders vote for the company's director nominees, supporting the board's strategic review amidst a proxy contest.

Pixelworks, Inc. has adjourned its Special Meeting of Shareholders to December 19, 2025, due to insufficient votes for the proposed sale of its Shanghai subsidiary.

Cannae Holdings highlights its successful $249 million investment in Black Knight Football, showcasing significant value creation through strategic acquisitions and operational improvements in European football clubs.

Syntec Optics Holdings, Inc. will hold its 2025 Annual Meeting to elect directors, ratify auditors, approve RSU grants, and amend its Certificate of Incorporation to modify voting requirements.

Visa's 2026 Definitive Proxy Statement highlights strong fiscal year 2025 results, strategic advancements in AI and stablecoins, and robust corporate governance practices, including board refreshment and officer liability amendments.

Paramount Skydance Corporation has initiated an all-cash tender offer to acquire Warner Bros. Discovery for $30.00 per share, challenging Netflix's prior merger agreement.

STAAR Surgical Company announced the expiration of its go-shop period for the Alcon merger, confirming no competing acquisition proposals were received.

International Business Machines Corporation announced a definitive agreement to acquire Confluent, Inc. for $31 per share in cash, valuing the data streaming pioneer at $11 billion.

SPX Technologies will acquire Crawford United Corporation for an estimated $300 million, expanding its HVAC portfolio with custom air-handling solutions.

Braemar Hotels & Resorts Inc. announced its Annual Meeting will be virtual-only and disclosed a lawsuit from Brancous, LP regarding rejected director nominations.

Novartis AG plans to acquire Avidity Biosciences for $12 billion, with Avidity spinning off its early-stage precision cardiology programs into a new independent entity, SpinCo.

Matthews International details strategic divestitures and debt reduction efforts while confirming a second director nomination challenge from Barington Capital L.P.

Metal Sky Star Acquisition Corporation seeks shareholder approval to extend its business combination deadline to January 5, 2027, and waive monthly extension fees, citing ongoing negotiations with potential targets.

Greenland Technologies Holding Corporation seeks shareholder approval for a dual-class share structure and reclassification that would grant its Chairman approximately 90% of voting power.

Alternus Clean Energy, Inc. announces a Board-approved reverse stock split ranging from 1-for-2 to 1-for-2,500 to improve marketability and liquidity of its common stock.

Callan JMB Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 29, 2025, to elect directors and ratify its independent auditor.

Vivakor, Inc. calls a Special Meeting to approve significant share issuances, a reverse stock split to maintain Nasdaq listing, and an increase in authorized capital.

Invesco QQQ Trust seeks shareholder approval to reclassify from a unit investment trust to an open-ended ETF, promising lower costs and enhanced governance.

BigBear.ai Holdings, Inc. has further adjourned its special meeting to December 19, 2025, to solicit additional votes for increasing authorized common stock from 500 million to 1 billion shares.

Abundia Global Impact Group, formerly Houston American Energy Corp., announced a name change reflecting its strategic shift towards sustainable fuels and energy transition technologies.

RYVYL Inc. reminds shareholders of its rescheduled Annual Meeting on December 15, 2025, where key proposals including director elections, auditor ratification, a potential reverse stock split, and an increase in authorized shares will be voted upon.

Strive, Inc. and Semler Scientific, Inc. plan to combine in an all-stock merger, creating a leading Bitcoin treasury and asset management firm.

Rani Therapeutics Holdings, Inc. completed a $60.3 million private placement and approved significant corporate governance changes, including reducing Class B voting power and eliminating stockholder written consent, to address financial needs and comply with Nasdaq rules.

Sphere 3D Corp. announced a Special Meeting of Shareholders on January 15, 2026, to vote on a warrant inducement transaction, a potential name change, and meeting adjournments.

Protagenic Therapeutics announces its virtual annual meeting on December 31, 2025, seeking stockholder ratification for a new independent accounting firm and detailing significant board composition changes.

Thumzup Media Corporation filed a Certificate of Correction to its Series A Preferred Convertible Voting Stock, clarifying anti-dilution provisions.

Reviva Pharmaceuticals Holdings, Inc. issued a supplement to its definitive proxy statement, correcting previously understated figures related to its proposed reverse stock split.

BioAtla, Inc. calls a Special Meeting to vote on issuing new shares for capital and a reverse stock split to maintain its Nasdaq listing.

Avenue Therapeutics, Inc. announced its virtual Annual Meeting of Stockholders for December 30, 2025, to elect directors and ratify KPMG LLP as its independent auditor.

Sphere 3D Corp. calls a special shareholder meeting to approve a warrant inducement transaction that raised $4.1 million and a name change to reflect its cryptocurrency mining focus.